VEK-99366-10798
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2021-09-16
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-31
Dose 1 — Pfizer-BioNTech
-
2021-09-16
Registered in v-safe
- 2021-09-16
- 2021-09-21
- 2021-09-30
- 2021-10-05
-
2021-10-13
Dose 2 — Pfizer-BioNTech
- 2021-10-14
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-19
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2021-11-24
-
2022-01-12
Survey response — 3 months, dose 2MedDRA: Back pain, Cough, Oropharyngeal discomfort, Pain in extremity — Feeling: Good · Be unable to work or attend schoolFree text: Throat discomfort Back pain Right leg pain CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-04-13
- 2022-10-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-31 | Pfizer-BioNTech | No |
| 2 | 2021-10-13 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 2
Symptoms: Throat discomfort Back pain Right leg pain Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal discomfort | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release